NATICK, Mass.--(BUSINESS WIRE)--Naveris, Inc., a leader in molecular diagnostics for viral cancers, today announced that the company and the principle investigator at Mayo Clinic will present its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results